This content is machine translated New anticoagulants Questions of practical application are to be clarified The new anticoagulants rivaroxaban, apixaban, and dabigatran promise several benefits, but are not suitable for all patient populations. Various questions arise in primary care practice, which were discussed at this…
View Post 5 min This content is machine translated SGIM Annual Meeting 2013 Osteoporosis – Diagnostic and therapeutic recommendations With regard to osteoporotic fractures, Switzerland is one of the high-risk countries together with Sweden and the USA. A 50-year-old Swiss woman has a 51.3% risk of suffering an osteoporotic…
